Internal Medicine, Cardiovascular Disease · Langhorne, PA
NPI
1144297219
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1203 Langhorne Newtown Rd, Suite 320
Langhorne, PA, 19047
Phone (215) 750-7818
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
2,937 services
Medicare patients, 2024
1,181
Average age 77
Drug cost, 2024
$2.4M
7,703 prescriptions
Company payments, 2025
$88K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rakesh Shah was code 99214 (office e&m - established), 663 times for 450 patients. In total Rakesh Shah billed 2,937 services in 55 codes, and Medicare paid $206K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 663 | 450 | $91.48 | $61K |
| 93000 Electrocardiogram | Office | 638 | 459 | $10.64 | $6,789 |
| 99233 Hospital E&M - Subsequent | Facility | 544 | 295 | $92.51 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 161 | 156 | $13.28 | $2,138 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 157 | 155 | $150.24 | $24K |
| 93306 Echocardiography (TTE/TEE) | Facility | 148 | 147 | $52.47 | $7,766 |
| 99223 Hospital E&M - Initial | Facility | 124 | 121 | $137.41 | $17K |
| 93010 Electrocardiogram | Facility | 58 | 53 | $6.03 | $350 |
| 93931 Duplex Scan - Extremity Arteries | Office | 53 | 53 | $80.51 | $4,267 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 38 | $63.28 | $2,595 |
| 93306 Echocardiography (TTE/TEE) | Office | 34 | 34 | $150.07 | $5,102 |
| 99204 Office E&M - New | Office | 30 | 30 | $128.36 | $3,851 |
| 93978 Duplex Scan - Extremity Arteries | Office | 29 | 27 | $123.51 | $3,582 |
| 99211 Office E&M - Established | Office | 25 | 25 | $16.83 | $421 |
| 99215 Office E&M - Established | Facility | 18 | 18 | $109.80 | $1,976 |
By year: 2022 $189K for 2,780 services; 2023 $214K for 2,926 services; 2024 $206K for 2,937 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 60 | 22 | $4.25 | $255 |
Medicare prescription drug claims, 2024
In 2024, the drug Rakesh Shah prescribed most often to Medicare patients was Atorvastatin Calcium, with 916 prescriptions and refills. In total Rakesh Shah wrote 7,703 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 916 | 2,636 | 293 | $16K |
| Metoprolol Succinate Generic | 714 | 1,992 | 213 | $13K |
| Ezetimibe Generic | 576 | 1,644 | 183 | $19K |
| Rosuvastatin Calcium Generic | 563 | 1,615 | 185 | $13K |
| Valsartan Generic | 538 | 1,567 | 176 | $29K |
| Amlodipine Besylate Generic | 485 | 1,403 | 155 | $3,630 |
| Eliquis Apixaban | 281 | 654 | 74 | $371K |
| Losartan Potassium Generic | 280 | 780 | 90 | $4,486 |
| Spironolactone Generic | 253 | 681 | 82 | $2,212 |
| Lisinopril Generic | 223 | 658 | 75 | $2,084 |
| Clopidogrel Clopidogrel Bisulfate | 195 | 524 | 58 | $3,148 |
| Carvedilol Generic | 186 | 542 | 66 | $2,096 |
| Farxiga Dapagliflozin Propanediol | 177 | 377 | 60 | $202K |
| Hydralazine Hcl Generic | 130 | 340 | 38 | $1,709 |
| Furosemide Generic | 120 | 309 | 46 | $569 |
Brand drugs: 998 claims; generic drugs: 6,705 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rakesh Shah $88K ($88K in general payments such as food, travel and fees) from 15 companies. The largest payer was Novo Nordisk Inc with $82K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 41 | $82K |
| Boston Scientific Corporation BSX | 2 | $5,024 |
| Endologix LLC | 2 | $328 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $188 |
| Alnylam Pharmaceuticals Inc. ALNY | 5 | $112 |
| Amgen Inc. AMGN | 5 | $103 |
| Pfizer Inc. PFE | 5 | $93.54 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $89.77 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $86.54 |
| BridgeBio Pharma, Inc. BBIO | 3 | $53.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.